CHPA Elects Board and Officers at Annual Executive Conference

Washington, D.C. (March 14, 2011)—Members of the board of directors of the Consumer Healthcare Products Association (CHPA) were elected at the association’s March 10-12 Annual Executive Conference. Paul L. Sturman, president and general manager, Pfizer Consumer Healthcare, was elected as the association’s chair. Christopher D. DeWolf, president & chief executive officer, Lil’ Drug Store Products, Inc., will serve as immediate past chair.

CHPA vice chairs:

  • Briain de Buitleir, vice president, NA Personal Health Care and Global Brand Franchise Leader Digestive Wellness, The Procter & Gamble Company;
  • Timothy G. Hayes, senior vice president & region head, North America; head, Global Business Development and Licensing, Bayer HealthCare LLC;
  • Patrick M. Lonergan, president, NUMARK Laboratories;
  • Peter B. Luther, president, North America OTC, McNeil Consumer Healthcare;
  • James J. Mackey, senior vice president, U.S. Region Head, Merck Consumer Care;
  • Brian J. McNamara, president and region head, OTC Americas, Novartis Consumer Health, Inc.; and
  • Jeffrey R. Needham, executive vice president and general manager, Consumer Health Care, Perrigo Company.

CHPA board members:

  • Christopher B. Ascher, co-owner/president, B.F. Ascher & Company, Inc.;
  • J.P. Borneman, Ph.D., chairman & chief executive officer, Hyland’s, Inc.;
  • Christopher B. Combe, chairman, Combe Incorporated;*
  • Michael J. Donnantuono, president & chief operating officer, Blistex Inc.;
  • Gary R. Downing, chief executive officer, Insight Pharmaceuticals Corp.;
  • Phillip W. Dritsas, president, Fleming Pharmaceuticals;
  • Scott R. Emerson, partner, DSE Healthcare Solutions, LLC;
  • Zan Guerry, chief executive officer, Chattem, Inc.;
  • Patrick Hennig, vice president, Marketing and Sales, Boehringer Ingelheim Pharmaceuticals, Inc.;
  • Jeffrey S. Himmel, chairman & chief executive officer, Himmel Pharmaceuticals Inc.;
  • Sheila Hopkins, vice president & general manager, Professional Oral Care, Colgate-Palmolive Company;
  • Edward C. Kuehnle, president, Catalina Marketing Services, Catalina Marketing Corporation;
  • David J. Long, vice president, Regional Regulatory & Medical Affairs, Reckitt Benckiser Inc.;
  • Colin I. Mackenzie, president, North America Consumer Healthcare, GlaxoSmithKline;*
  • Matthew M. Mannelly, chief executive officer, Prestige Brands Holdings, Inc.;
  • Diane K. Manwaring, president, North America, Lansinoh Laboratories, Inc.;
  • Daren Mazzucca, publisher, Midwest Living, Meredith Corporation;*
  • James L. Medford, president, chief executive officer, and chairman of the board, Aaron Industries, Inc.;
  • Dennis M. O’Donnell, R.Ph., president & chief executive officer, Matrixx Initiatives, Inc.;*
  • Adam D. Raczkowski, president and chief operating officer, W.F. Young, Inc.;
  • Jeffrey R. Rowan, president and chief executive officer, Fleet Laboratories;
  • Paul Scoggins, general manager, Johnson & Johnson•Merck Consumer Pharmaceuticals Co.;*
  • Bill Seiden, senior vice president, U.S. Sales & Marketing, Taro Pharmaceuticals U.S.A., Inc.;
  • Randy M. Sloan, president and chief executive officer, Lornamead, Inc.;
  • Neill B. Walsdorf, Jr., president, Mission Pharmacal Company;
  • David J. Wendland, vice president, Hamacher Resource Group;*
  • Robert M. Wengel, senior vice president, Professional Services, The Nielsen Company;
  • Steven B. Woolf, executive vice president & chief financial officer, Humco Holding Group, Inc.;*
  • Akiyoshi Yoshida, Ph.D., president and chief executive officer, The Mentholatum Company; and
  • Michael A. Zeher, president & chief executive officer, Nutrition 21, Inc.

Serving on the board ex officio as a committee chair:

  • Susan E. James, vice president, Worldwide Regulatory Affairs, Compliance and Quality, GlaxoSmithKline (Regulatory & Scientific Affairs Committee chair);
  • Thomas M. Millikin, associate director, Worldwide External Relations, Personal Health Care, The Procter & Gamble Company (Public Affairs Committee chair);
  • Peter N. Stevens, Esq., assistant general counsel, Consumer Healthcare, GlaxoSmithKline (Government Affairs Committee chair); and
  • Paul J. Weninger, vice president, Consumer Healthcare Global Quality Operations, Perrigo Company (Manufacturing Controls Committee chair).

*denotes newly elected to this position

Contact: Elizabeth Funderburk, 202.429.9260


CHPA is the 130-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplements.